PharmaCyte Biotech Inc (PMCB)

[bulldurham]

There might be a misunderstanding on the CHARDAN CAPITAL Deal...with it being an "At the Market" banking agreement...which was laid out very clearly in the PR...under which Nuvilex may seek to raise up to a total of $50,000,000 depending upon market conditions and at the discretion of Nuvilex...In the banking agreement, Chardan Capital Markets will act as the exclusive placement agent for Nuvilex...meaning they will be the agent for any offering if or when Nuvilex wants needs to ...The funds will be used for: (i) late-phase clinical trials in pancreatic cancer with Clinical Network Services (CNS) in Australia; (ii) preclinical studies and clinical trials with Translational Drug Development (TD2) to address the symptoms of pancreatic cancer to be conducted in the U.S.; and (iii) further testing and research for diabetes in Europe.

now keep in mind that they don't ever have to do an offering depending on what happens in the future for Nuvilex and we all know that they have things in the works...

I hope this clears things up ...
bull